A qualitative examination of responses from a survey of pharmacy staff in Georgia regarding access to Narcan®. Issue 4 (22nd January 2022)

• Record Type: Journal Article
• Authors: Griner, Thomas; Strasser, Sheryl
• Is Part Of: Health education research. Volume 36:Issue 4(2021)
• Page Start: 467
• Page End: 477
• Publication Date: 2022-01-22
• Subjects: Health education -- Periodicals; Health education -- Study and teaching -- Periodicals; 613.071
• DOI: 10.1093/her/cyab024
• Languages: English
• ISSNs: 0268-1153

Abstract

Abstract: Georgia state lawmakers enacted legislation designed to reduce opioid overdose deaths by increasing public access to rescue products, such as Narcan®. This article explores whether pharmacy employees have effectively adopted such changes into pharmacy practice. We analyzed unsolicited remarks noted during a parent telephone survey of 120 Georgia pharmacy staff regarding price, availability and barriers to layperson purchase of Narcan®. Comments regarding dispensing requirements and challenges in obtaining inventory and changes in communication style were recorded. Around 15% were unfamiliar with Narcan® as an opioid overdose reversal agent or were unaware of their pharmacy's policies governing its sale. Nearly half of those contacted did not have Narcan® in stock with some reporting that receiving Narcan® would take several days after placing an order. Over half specified requirements for purchasing Narcan® not required by law. Fewer than 15% had Narcan® available and imposed no unnecessary requirements for its purchase. During approximately 10% of the survey calls, respondents used a tone of voice or made comments suggestive of bias. We conclude that non-compliance with current laws, lack of familiarity with Narcan® and negative communication tendencies that suggest implicit bias and stigmatizing behaviors could ultimately inhibit access to opioid overdose treatment.